NOVO-NORDISK $158.76

down -3.11


19/6/2013 04:19 PM  |  NYSE : NVO  |  Industries : Manufacturing / Pharmaceutical and Medicine Manufacturing
Quotes displayed are delayed by 15 minutes. Market data is provided by Telvent DTN
Get Trend Analysis Icon Get NVO Trend Analysis - it has underperformed the S&P 500 by 7%

ETF Alternatives



People viewing NVO also viewed: , , , ,

Competitors

Ticker Name Volume % Change
ACEL TAMIR BIOTECHNOLOGY 5.5K +1.50%
WPHM WINSTON PHARMACEUTICALS 20.0K +1.50%
CKGT CHINA KANGTAI CACTUS BIO 500.0 +1.11%
MLGGY MELDEX INTERNATIONAL 300.0 +1.00%
PARS PHARMOS 3.2K +0.73%
View All

NVO Stock Analysis

  1.

    Positive Data on Novartis' Jakavi - Analyst Blog

    (NVS,CBST,NVO,INCY )
    Novartis recently presented positive results on oncology drug Jakavi from a three-year follow up analysis of a phase III trial, COMFORT II.

  2. Encouraging Data on Novartis' Gilenya - Analyst Blog

    (NVS,CBST,NVO,BIIB )
    Novartis recently presented new data on Gilenya from a phase III study, TRANSFORMS.

  3. Lilly Alzheimer's Study Terminated - Analyst Blog

    (PFE,LLY,NVO,JNJ )
    The phase II study was voluntarily terminated due to the identification of abnormal liver biochemical tests during routine monitoring.
  4.

    Sanofi's Fluzone Quadrivalent Gets FDA Nod - Analyst Blog

    (SNY,AZN,NVO,GSK )
    Sanofi announced that the FDA has cleared its quadrivalent formulation of Fluzone
  5.

    CHMP Positive on Sanofi's Lantus - Analyst Blog

    (SNY,AZN,LLY,NVO )
    The Committee for Medicinal Products for Human Use issued a positive opinion related to Lantus
  6.

    FDA Panel Positive on GSK's Avandia - Analyst Blog

    (SNTS,SNY,NVO,GSK )
    The FDA panel recently voted in favor of easing safety restrictions related to Glaxo's Avandia.
  7.

    Investing For The Global Diabetes Epidemic

    (MCD,NVO,RVP,WST,BDX,PODD,MNKD,DVA,LLY,SNY )
    Sadly, diabetes is quickly becoming a global epidemic. Within these grim statistics, investors can find opportunities with the companies that are fighting this epidemic.

  8. Amgen Chased By The Bubble

    (AMGN,PFE,SNY,TEVA,CELG,NVO,MRK,HSP,ABT,AFFY,BIIB,GILD )
    Amgen really needs the pipeline to come through to support this valuation.
Free Reports
  1.

    5 Chart Patterns Every Investor Needs To Know

    Learn How to Use Technical Analysis to Your Advantage.
  2.

    Free Investment Report: 6 Must-Own Emerging Market Stocks

    Gain Valuable Insights into International and Emerging Markets That are Poised for Explosive Growth!
  3.

    7 Proven Strategies for Market-Stomping Stocks

    Discover Investing Strategies that will Benefit Every Investor Today!
Marketplace
Trading Center